Consultant Medical Oncologist, Royal Marsden Hospital, Professor of Thoracic Oncology, Institute of Cancer Research

Professor Popat is Chair of Thoracic Oncology at The Institute of Cancer Research and Consultant Medical Oncologist at The Royal Marsden Hospital where he is Head of the Lung Unit and Head of the Lung Research programme. He is an internationally recognized expert in the treatment of thoracic malignancies.
His primary research interests include the complexities of cancer genomics, optimization of testing and implementation of genomic testing into routine clinical practice, as well as developing novel drug treatments through clinical trials.
He has published over 300 papers with over 17,000 citations, including influential trial manuscripts in oncogene-addicted NSCLC and mesothelioma, leading to global licensing, reimbursement in multiple territories, and recommendations in international treatment guidelines. He has co-authored European guidelines for the treatment of small cell lung cancer, non-small cell lung cancer, mesothelioma, and ctDNA use.
Nationally, he is founding chair of the British Thoracic Oncology Group (BTOG) Research Group and is immediate past chair of the BTOG Steering Committee and past co-Director for the Cancer division of the UK South London Clinical Research Network. Internationally, he sits on the Foundation Council of the European Thoracic Oncology Platform (ETOP) and holds several roles in the European Society of Medical Oncology (ESMO).